BRISTOL-MYERS SQUIBB $47.40

up +0.40


24/5/2013 04:24 PM  |  NYSE : BMY  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
12 Mo. Price Change : 44% - BMY has outperformed the S&P 500 by 19%

Get Trend Analysis Icon Get Trend Analysis

ETF Alternatives sponsored by



People viewing BMY also viewed: , , , ,

Competitors

Ticker Name Volume % Change
NPCUF ALLON THERAPEUTICS INC 10.0K +1.78%
CNSO CNS RESPONSE 34.1K +1.26%
ISLT ISLET SCIENCES 78.6K +0.75%
ADLS ADVANCED LIFE SCIENCES 35.1K +0.67%
SCLR SCOLR PHARMA 427.3K +0.67%
View All

BMY Stock Analysis

  1.

    Roche, Reloaded

    (RHHBY,BMY,GILD,MRK,JNJ )
    Roche has one of the best long-term growth profiles in the Big Pharma space
  2.

    After A Big Rally, Pfizer Might Need Some Rest

    (PFE,BMY,MRK,RHHBY )
    A big rally has brought Pfizer back to fair value.
  3.

    Adasuve Deal Is Very Good For Alexza, But What About Teva?

    (ALXA,TEVA,VRX,BMY,LLY )
    Teva's partnership with Alexza looks like an expensive gamble.
  4.

    The “Healthy” Play In Contract Research Organizations

    (CVD,ICLR,PXRL,AMRI,MRK,CRL,CG,JPM,BMY,PFE )
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane clinical trial and lab work. This outsourcing will be a big win for the contract research organizations.
Free Reports
  1.

    5 Chart Patterns Every Investor Needs To Know

    Learn How to Use Technical Analysis to Your Advantage.
  2.

    Forbes Quant Model: 3 Top Stocks

    Using Forbes’ exclusive Quant Model, we’ve chosen three stocks that we think could double in price in the next 12 months.
  3.

    Forbes Wolfe Nanotech Report Nanotech 101

    Get this Rare, First-Person Account of the Nanotechnology Industry, Absolutely Free!
Marketplace
Trading Center